ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

DSA Detected by ELISA-PRA Is Associated With High Risk for Development of AMR in Stable Kidney Transplant Recipients

D. Lee,1 J. Kim,2 B. Kim,3 M. Chun,4 I. Kim.5

1Medicine, Division of Nephrology, Maryknoll General Hospital, Busan, Republic of Korea
2Surgery, Maryknoll General Hospital, Busan, Republic of Korea
3Laboratory Medicine, Maryknoll General Hospital, Busan, Republic of Korea
4Pathology, Maryknoll General Hospital, Busan, Republic of Korea
5Urology, Maryknoll General Hospital, Busan, Republic of Korea.

Meeting: 2015 American Transplant Congress

Abstract number: A131

Keywords: Antibodies, HLA antibodies, Plasmapheresis, Rejection

Session Information

Session Name: Poster Session A: Kidney Antibody Mediated Rejection

Session Type: Poster Session

Date: Saturday, May 2, 2015

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Exhibit Hall E

Background: Donor specific anti-HLA antibodies (DSA) are a major cause of antibody mediated rejection (AMR) and allograft loss, determining how to monitor patients for DSA and how to treat them is important. The purpose of this study was to evaluate the incidence of presence of DSA and the associations of DSA levels and development of AMR in stable kidney transplant recipients (KTRs).

Methods: We screened 208 stable KTRs by HLA-specific ELISA-PRA (panel reactive antibody) for DSA from July 2013 to June 2014. We compared the incidence of AMR, histopathologic finding and clinical parameters between Group 1(DSA-positive, n=13) and Group2 (DSA-negative, n=14).

Results: Time to biopsy after transplantation was 74.3 (6-154.6) months. The median age of recipient and donor was 37.5 (24-59) years and 39 (20-64) years, respectively. 55% were female. Median serum creatinine level at the time of biopsy was 1.25(0.6-2.3) mg/dl and FK level 5.9 (4.5-8.1) ng/ml. 27 (12.9%) had positive ELISA-PRA were biopsied. Median PRA level was 7.5% (2.5-47.5). In Group 1, 13 had DSAs [class I (n=6), class II (n=5) and class 1&2 (n=2)]. Group 1 had a significantly higher risk for development of AMR than Group 2 [10(76.9%) of 13 patients vs.1 (7.1%) of 14 patients, p<0.001].

After patients with AMR were treated with plasmapheresis (PP) with IVIG [4(4-7)] and anti-CD20 antibody, anti-class I PRA level reduced by -7.1%(-28.5∼-3.6) and class II PRA level was reduced by 0% (-16.7∼33.3).

Class I DSA is more effectively removed than class II [class I DSA persisted in 2 (40%) of 5 patients vs. class II DSA persisted in 6(85.7%) of 7 patients]. All 27 patients had stable graft function and serum creatinine level at last visit was 1.2(0.7-2.3) mg/dl.

Conclusions: Our study demonstrated that DSA detected by ELISA-PRA is associated with high risk for development of AMR in stable KTRs. Routine monitoring of DSA with ELISA-PRA and subsequent allograft biopsy may be useful to recognize development of AMR. Class II DSA seems to be more resistant to treatment of AMR than class I DSA, however, long term effect of PP, IVIG and anti-CD20 antibody on AMR to remove DSA still remains unknown.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lee D, Kim J, Kim B, Chun M, Kim I. DSA Detected by ELISA-PRA Is Associated With High Risk for Development of AMR in Stable Kidney Transplant Recipients [abstract]. Am J Transplant. 2015; 15 (suppl 3). https://atcmeetingabstracts.com/abstract/dsa-detected-by-elisa-pra-is-associated-with-high-risk-for-development-of-amr-in-stable-kidney-transplant-recipients/. Accessed May 8, 2025.

« Back to 2015 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences